Alon Yasovsky, CEO of SensoGenic – an eHV Portfolio Company, Accepted to Prestigious Merage Program

We are proud to announce that Alon Yasovsky, CEO of SensoGenic, an eHealth Ventures company developing innovative solutions for food allergen detection has been accepted to the prestigious US-Israel Innovation leadership program initiated by the Merage Institute, for the class of October 2018.

The Merage Institute Leadership Program for Life Science & Medical Devices Executives focuses on enhancing the ability of the participating CEOs and their respective companies to operate in the United States and to succeed in the global marketplace.

The program provides highly effective approaches to successful marketing, negotiation techniques, applied networking and sales strategies, finance, and legal and procurement issues for Israeli entrepreneurs operating in the U.S. market. Faculty members include some of the most effective U.S. entrepreneurs as well as experts from leading U.S. business schools. Faculty lead the participants through highly interactive sessions that include relevant case studies, simulations, and project-focused assignments.

The integrated program features an innovative business development component beginning  with introductions to relevant U.S. entrepreneurs possibly interested in cooperating with value-adding Israeli businesses. This relationship begins during coursework in the program and expands on a continuous basis as the CEO and the firm develop over the years.

Previous participants from eHealth Ventures include Ophir Shahaf (eHealth Ventures VP of Business Development) and Ophir Atar (CEO, MindsEye).